Model
Edge
BioCryst Pharmaceuticals Inc
0001718020
Filing Type
4
Filing Date
6/16/2024
Updated
6/17/24, 2:31 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership